New diabetes clinical trial: Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes
Published on: October 10, 2022 at 11:00AM
Conditions: Essential Hypertension; Diabetes Mellitus, Type 2
Interventions: Drug: ATB-1011; Drug: ATB-1012; Drug: ATB-1013; Drug: ATB-1011 placebo; Drug: ATB-1012 placebo; Drug: ATB-1013 placebo
Sponsor: Autotelicbio
Not yet recruiting
https://ift.tt/ef5A2ol
Conditions: Essential Hypertension; Diabetes Mellitus, Type 2
Interventions: Drug: ATB-1011; Drug: ATB-1012; Drug: ATB-1013; Drug: ATB-1011 placebo; Drug: ATB-1012 placebo; Drug: ATB-1013 placebo
Sponsor: Autotelicbio
Not yet recruiting
https://ift.tt/ef5A2ol
Comments
Post a Comment